Troy Wilson

Troy E.
Wilson is the founder of Kura Oncology, Inc., founded in 2014, serving as Chairman, President, CEO & Chief Financial Officer.
Dr. Wilson was the founder of Ambrx, Inc., founded in 2003, serving as Chief Business Officer.
Dr. Wilson was the founder of Intellikine LLC, founded in 2007, serving as President, Chief Executive Officer & Director.
Dr. Wilson was the founder of Avidity Biosciences, Inc., founded in 2012, serving as Non-Executive Chairman.
Dr. Wilson was the founder of Araxes Pharma LLC, founded in 2012, serving as President, CEO, Director & Managing Member.
Dr. Wilson is also the founder of Wildcat Discovery Technologies, Inc...
Current positions include Executive Chairman at Abintus Bio, Inc. since 2020, Independent Director at Puma Biotechnology, Inc. since 2013, Director at Atrium Therapeutics, Inc. starting 2026, Director at Cipher Genetics, Inc., Director at Cartography Biosciences, Inc., and Director at Montara Therapeutics, Inc. Former positions include Chairman, President & Chief Executive Officer at Zeta Acquisition Corp.
III, Chief Executive Officer at Takeda Pharmaceuticals U.S.A., Inc., Executive Chairman at Wellspring Biosciences LLC from 2019 to 2023, Director at ZP Opco, Inc., Independent Director at Zosano Pharma Corp.
from 2014 to 2019, Founding Partner at Presidio Partners, and Vice President-Business Development at Novartis Institute for Functional Genomics, Inc. Education includes graduate studies at New York University and undergraduate and doctorate degrees from the University of California, Berkeley.